Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ANIP
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $70.80 | $35.4K Sale | Form 4 ↗ |
| Oct 29, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,850 | $72.87 | $207.7K Sale | Form 4 ↗ |
| Oct 15, 2026 | Nikhil Lalwani PRESIDENT & CEO, Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 5,400 | $71.89 | $388.2K Sale | Form 4 ↗ |
| Sep 29, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,850 | $73.00 | $208.1K Sale | Form 4 ↗ |
| Sep 15, 2026 | Nikhil Lalwani PRESIDENT & CEO, Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 5,400 | $71.00 | $383.4K Sale | Form 4 ↗ |
| Sep 14, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $70.79 | $35.4K Sale | Form 4 ↗ |
| Sep 11, 2026 | Jeanne Thoma Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 1,000 | $71.53 | $71.5K Sale | Form 4 ↗ |
| Aug 31, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,850 | $72.80 | $207.5K Sale | Form 4 ↗ |
| Aug 25, 2026 | Nikhil Lalwani PRESIDENT & CEO, Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 5,400 | $74.30 | $401.2K Sale | Form 4 ↗ |
| Aug 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $75.48 | $37.7K Sale | Form 4 ↗ |
| Aug 10, 2026 | Ori Gutwerg SVP, GENERICS | ANIP ANI Pharmaceuticals, Inc. | Sale | 3,162 | $77.00 | $243.5K Sale | Form 4 ↗ |
| Jul 29, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,850 | $81.36 | $231.9K Sale | Form 4 ↗ |
| Jul 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $81.84 | $40.9K Sale | Form 4 ↗ |
| Jul 2, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 3,313 | $86.00 | $284.9K Sale | Form 4 ↗ |
| Jun 29, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,850 | $84.12 | $239.7K Sale | Form 4 ↗ |
| Jun 12, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $82.03 | $41.0K Sale | Form 4 ↗ |
| Jun 8, 2026 | Thomas Haughey Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,000 | $80.88 | $161.8K Sale | Form 4 ↗ |
| Jun 5, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 3,312 | $80.00 | $265.0K Sale | Form 4 ↗ |
| May 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $78.16 | $39.1K Sale | Form 4 ↗ |
| May 13, 2026 | Patrick D. Walsh Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 10,000 | $80.63 | $806.3K Sale | Form 4 ↗ |
| May 12, 2026 | Ori Gutwerg SVP, GENERICS | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,772 | $79.50 | $220.4K Sale | Form 4 ↗ |
| May 12, 2026 | Thomas Andrew Rowland SVP, HEAD - ESTABLISHED BRANDS | ANIP ANI Pharmaceuticals, Inc. | Sale | 459 | $79.21 | $36.4K Sale | Form 4 ↗ |
| May 11, 2026 | Nikhil Lalwani PRESIDENT & CEO, Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 55,000 | $77.57 | $4.3M Sale | Form 4 ↗ |
| May 11, 2026 | Patrick D. Walsh Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 3,973 | $80.75 | $320.8K Sale | Form 4 ↗ |
| Apr 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $77.95 | $39.0K Sale | Form 4 ↗ |
| Mar 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $72.62 | $36.3K Sale | Form 4 ↗ |
| Mar 13, 2026 | Christopher Mutz HEAD OF RARE DISEASE | ANIP ANI Pharmaceuticals, Inc. | Sale | 3,162 | $71.64 | $226.5K Sale | Form 4 ↗ |
| Mar 11, 2026 | Thomas Andrew Rowland SVP, HEAD - ESTABLISHED BRANDS | ANIP ANI Pharmaceuticals, Inc. | Sale | 4,772 | $74.91 | $357.5K Sale | Form 4 ↗ |
| Mar 9, 2026 | Krista Davis SVP, CHIEF HR OFFICER | ANIP ANI Pharmaceuticals, Inc. | Sale | 5,087 | $74.13 | $377.1K Sale | Form 4 ↗ |
| Mar 9, 2026 | Christopher Mutz HEAD OF RARE DISEASE | ANIP ANI Pharmaceuticals, Inc. | Sale | 3,602 | $74.18 | $267.2K Sale | Form 4 ↗ |
| Mar 6, 2026 | Krista Davis SVP, CHIEF HR OFFICER | ANIP ANI Pharmaceuticals, Inc. | Sale | 1,485 | $75.00 | $111.4K Sale | Form 4 ↗ |
| Mar 6, 2026 | Christopher Mutz HEAD OF RARE DISEASE | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,121 | $74.22 | $157.4K Sale | Form 4 ↗ |
| Mar 5, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 4,000 | $75.56 | $302.2K Sale | Form 4 ↗ |
| Mar 5, 2026 | Stephen P. Carey SVP & CFO | ANIP ANI Pharmaceuticals, Inc. | Sale | 3,312 | $75.42 | $249.8K Sale | Form 4 ↗ |
| Mar 3, 2026 | Ori Gutwerg SVP, GENERICS | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,060 | $76.50 | $157.6K Sale | Form 4 ↗ |
| Mar 3, 2026 | Patrick D. Walsh Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 6,000 | $74.23 | $445.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Christopher Mutz HEAD OF RARE DISEASE | ANIP ANI Pharmaceuticals, Inc. | Sale | 417 | $74.00 | $30.9K Sale | Form 4 ↗ |
| Feb 20, 2026 | Krista Davis SVP, CHIEF HR OFFICER | ANIP ANI Pharmaceuticals, Inc. | Sale | 1,730 | $77.99 | $134.9K Sale | Form 4 ↗ |
| Feb 20, 2026 | Christopher Mutz HEAD OF RARE DISEASE | ANIP ANI Pharmaceuticals, Inc. | Sale | 5,323 | $78.02 | $415.3K Sale | Form 4 ↗ |
| Feb 19, 2026 | Krista Davis SVP, CHIEF HR OFFICER | ANIP ANI Pharmaceuticals, Inc. | Sale | 2,084 | $77.53 | $161.6K Sale | Form 4 ↗ |
| Feb 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $76.80 | $38.4K Sale | Form 4 ↗ |
| Feb 12, 2026 | Christopher Mutz HEAD OF RARE DISEASE | ANIP ANI Pharmaceuticals, Inc. | Sale | 7,032 | $76.55 | $538.3K Sale | Form 4 ↗ |
| Jan 13, 2026 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 500 | $84.33 | $42.2K Sale | Form 4 ↗ |
| Dec 18, 2025 | Krista Davis SVP, CHIEF HR OFFICER | ANIP ANI Pharmaceuticals, Inc. | Sale | 1,622 | $82.40 | $133.7K Sale | Form 4 ↗ |
| Dec 12, 2025 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 400 | $82.32 | $32.9K Sale | Form 4 ↗ |
| Dec 5, 2025 | Renee P. Tannenbaum Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 1,800 | $81.15 | $146.1K Sale | Form 4 ↗ |
| Nov 13, 2025 | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | ANIP ANI Pharmaceuticals, Inc. | Sale | 400 | $87.27 | $34.9K Sale | Form 4 ↗ |
| Nov 13, 2025 | Chad Gassert SVP - CORP. DEV. & STRATEGY | ANIP ANI Pharmaceuticals, Inc. | Sale | 94 | $88.00 | $8,272 Sale | Form 4 ↗ |
| Nov 13, 2025 | Patrick D. Walsh Director | ANIP ANI Pharmaceuticals, Inc. | Sale | 8,643 | $86.88 | $750.9K Sale | Form 4 ↗ |
| Nov 12, 2025 | Chad Gassert SVP - CORP. DEV. & STRATEGY | ANIP ANI Pharmaceuticals, Inc. | Sale | 14,642 | $89.07 | $1.3M Sale | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:38 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances